Difficulty: Medium
Average Score: 67%
Practice
A nurse is taking care of a client with cancer and is teaching about the types of drugs that promote the natural production of blood cells in people whose own hematopoietic functions have become compromised. What class of drugs are these?
Correct answer
B
Rationale
In this scenario, the correct answer is B) Colony-stimulating factors. Colony-stimulating factors are a class of drugs that stimulate the bone marrow to produce more blood cells, including white blood cells, red blood cells, and platelets. This is crucial for individuals with compromised hematopoietic functions, such as cancer patients undergoing chemotherapy, as these treatments can suppress bone marrow function.
Option A) Tumor necrosis factors are involved in inflammation and cell death processes, not in promoting blood cell production. Option C) Interferons are used in the treatment of viral infections and cancer, but they do not directly stimulate blood cell production. Option D) Interleukins are involved in immune regulation and inflammation, but they are not primarily responsible for promoting blood cell production.
Educationally, understanding the role of colony-stimulating factors in promoting blood cell production is essential for nurses caring for patients with hematologic disorders or undergoing treatments that affect blood cell counts. Knowing the correct drugs to administer to support hematopoiesis can significantly impact patient outcomes and quality of life.
Option A) Tumor necrosis factors are involved in inflammation and cell death processes, not in promoting blood cell production. Option C) Interferons are used in the treatment of viral infections and cancer, but they do not directly stimulate blood cell production. Option D) Interleukins are involved in immune regulation and inflammation, but they are not primarily responsible for promoting blood cell production.
Educationally, understanding the role of colony-stimulating factors in promoting blood cell production is essential for nurses caring for patients with hematologic disorders or undergoing treatments that affect blood cell counts. Knowing the correct drugs to administer to support hematopoiesis can significantly impact patient outcomes and quality of life.